Rescuing Antibiotics from Bacterial Resistance

Lead Research Organisation: University of Cambridge
Department Name: Genetics

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
 
Description This short (2 month) project has provided an opportunity to test reports that indole modulates E. coli antibiotic resistance and to assess whether interference with this process might offer an opportunity for enhancing the activity of existing antibacterial drugs. We explored developing high throughput (96 well plate) methods for quantifying the effect of indole on antibiotic resistance and discovered that they were less suitable than conventional plating methods for measurement of MIC. By comparing the antibiotic resistance of indole-producing and non-producing strains we were able to show that enhancement is likely to be possible for only a sub-set of antibiotics. This was an important discovery and has focussed subsequent efforts on those drugs where a good outcome is most likely.
Exploitation Route The findings provide a basis for future work on ways that modulating indole synthesis might be used to enhance the efficacy of commonly used antibiotics. The findings have provided an essential foundation for subsequent work.
Sectors Healthcare,Pharmaceuticals and Medical Biotechnology

 
Description The findings have significant potential to create impact in the enhancement of antibacterial drugs. However further work will be required before this can be achieved. Studies based upon the Pathfinder grant are on-going in the Summers laboratory. The initial findings from the award have led directly to projects for two BBSRC rotation students, one M.Phil student , one summer internship (from Delhi) and two visiting Masters students (Heidelberg & Leiden). These additional projects have advanced our understanding of the role of indole signalling in antibiotic resistance and are enabling us to formulate (1) plans for further grant applications and (2) an in silicon screening project as a first step in the design of anti-persister drugs.
First Year Of Impact 2016
Sector Education,Pharmaceuticals and Medical Biotechnology
 
Description SBRI Antimicrobial in Humans (AMR) Competition
Amount £483,356 (GBP)
Funding ID 106583-623230 
Organisation Innovate UK 
Sector Public
Country United Kingdom
Start 01/2019 
End 12/2019
 
Description Schools outreach lecture 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Schools
Results and Impact Approx 400 school pupils attended a talk on "Genes Going Sideways" as part of a day to encourage applications to Cambridge.
Year(s) Of Engagement Activity 2018